A TRIAL OF CARBAMAZEPINE IN BORDERLINE PERSONALITY-DISORDER

被引：63

作者：

DELAFUENTE, JM

LOTSTRA, F

机构：

[1] Department of Psychiatry, Erasme Hospital, Free University of Brussels (ULB), B-1070 Brussels

来源：

EUROPEAN NEUROPSYCHOPHARMACOLOGY | 1994年 / 4卷 / 04期

关键词：

BORDERLINE PERSONALITY DISORDER; CARBAMAZEPINE;

D O I：

10.1016/0924-977X(94)90296-8

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Borderline personality disorder does not have a first choice pharmacological treatment. We studied 20 borderline inpatients in a double-blind parallel placebo-controlled trial with carbamazepine for a mean of 30.9 days. No significant positive effects of the drug were found.

引用

页码：479 / 486

页数：8

共 62 条

[1]

AKISKAL HS, 1981, PSYCHIAT CLIN N AM, V4, P25

[2]

AKISKAL HS, 1985, AM J PSYCHIAT, V142, P192

[3]

ANDRULONIS PA, 1981, PSYCHIAT CLIN N AM, V4, P47

[4] BORDERLINE PERSONALITY SUB-CATEGORIES [J].